| European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 M Baccarani, MW Deininger, G Rosti, A Hochhaus, S Soverini, ... Blood, The Journal of the American Society of Hematology 122 (6), 872-884, 2013 | 2552 | 2013 |
| Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL … T Hughes, M Deininger, A Hochhaus, S Branford, J Radich, J Kaeda, ... Blood 108 (1), 28-37, 2006 | 1527 | 2006 |
| International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with> 30% blasts H Dombret, JF Seymour, A Butrym, A Wierzbowska, D Selleslag, JH Jang, ... Blood, The Journal of the American Society of Hematology 126 (3), 291-299, 2015 | 1295 | 2015 |
| Inotuzumab ozogamicin versus standard therapy for acute lymphoblastic leukemia HM Kantarjian, DJ DeAngelo, M Stelljes, G Martinelli, M Liedtke, W Stock, ... New England Journal of Medicine 375 (8), 740-753, 2016 | 1259 | 2016 |
| Prevention of high-dose chemotherapy–induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition D Cardinale, A Colombo, MT Sandri, G Lamantia, N Colombo, M Civelli, ... Circulation 114 (23), 2474-2481, 2006 | 1178 | 2006 |
| Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy D Cardinale, MT Sandri, A Colombo, N Colombo, M Boeri, G Lamantia, ... Circulation 109 (22), 2749-2754, 2004 | 1160 | 2004 |
| Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML AE Perl, G Martinelli, JE Cortes, A Neubauer, E Berman, S Paolini, ... New England Journal of Medicine 381 (18), 1728-1740, 2019 | 1010 | 2019 |
| Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project M Federico, M Bellei, L Marcheselli, S Luminari, A Lopez-Guillermo, ... Journal of Clinical Oncology 27 (27), 4555-4562, 2009 | 849 | 2009 |
| BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European … S Soverini, A Hochhaus, FE Nicolini, F Gruber, T Lange, G Saglio, F Pane, ... Blood, The Journal of the American Society of Hematology 118 (5), 1208-1215, 2011 | 722 | 2011 |
| Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly× 4 … M Ghielmini, SFH Schmitz, SB Cogliatti, G Pichert, J Hummerjohann, ... Blood 103 (12), 4416-4423, 2004 | 722 | 2004 |
| Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia G Bucaneve, A Micozzi, F Menichetti, P Martino, MS Dionisi, G Martinelli, ... New England Journal of Medicine 353 (10), 977-987, 2005 | 702 | 2005 |
| Platelet gel for healing cutaneous chronic wounds G Crovetti, G Martinelli, M Issi, M Barone, M Guizzardi, B Campanati, ... Transfusion and Apheresis Science 30 (2), 145-151, 2004 | 685 | 2004 |
| Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy D Cardinale, MT Sandri, A Martinoni, A Tricca LabTech, M Civelli, ... Journal of the American College of Cardiology 36 (2), 517-522, 2000 | 683 | 2000 |
| Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia S Soverini, S Colarossi, A Gnani, G Rosti, F Castagnetti, A Poerio, ... Clinical Cancer Research 12 (24), 7374-7379, 2006 | 636 | 2006 |
| Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia Italian Cooperative Study Group on Chronic Myeloid Leukemia New England Journal of Medicine 330 (12), 820-825, 1994 | 607 | 1994 |
| Patterns of outcome and prognostic factors in primary large cell lymphoma of the testis in a survey of 373 patients by the International Extranodal Lymphoma Study Grfoup (IELSG). E Zucca, A Conconi, TI Mughal, AH Sarris, JF Seymour, U Vitolo, R Klasa, ... Journal of Clinical Oncology 21, 20-27, 2003 | 564 | 2003 |
| Resting and activated endothelial cells are increased in the peripheral blood of cancer patients P Mancuso, A Burlini, G Pruneri, A Goldhirsch, G Martinelli, F Bertolini Blood, The Journal of the American Society of Hematology 97 (11), 3658-3661, 2001 | 558 | 2001 |
| Very young women (< 35 years) with operable breast cancer: features of disease at presentation M Colleoni, N Rotmensz, C Robertson, L Orlando, G Viale, G Renne, ... Annals of Oncology 13 (2), 273-279, 2002 | 539 | 2002 |
| Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results HM Kantarjian, FJ Giles, KN Bhalla, J Pinilla-Ibarz, RA Larson, ... Blood, The Journal of the American Society of Hematology 117 (4), 1141-1145, 2011 | 506 | 2011 |
| Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study AE Perl, JK Altman, J Cortes, C Smith, M Litzow, MR Baer, D Claxton, ... The Lancet Oncology 18 (8), 1061-1075, 2017 | 503 | 2017 |
